Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exisulind for Duodenal Polyps in FAP
NCT00026468Phase 3Withdrawn
- Sponsor
- University of Utah
- Start
- Jul 1999
- Primary completion
- Jul 1999
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of exisulind in familial adenomatous polyposis (FAP), sponsored by University of Utah. Planned start Jul 1999; status: withdrawn.
02
Drugs
exisulind
03
Conditions
familial adenomatous polyposis (FAP)
Beyond the preview
Go deeper on NCT00026468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00026468.